<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">Table 
 <xref rid="Tab2" ref-type="table">2</xref> presents a summary of 21 included studies. The review included 28,387 COVID-19, 6 SARS-CoV and 2 MERS-CoV participants with HIV/TB or TB. Among them, 1294 were COVID-19/TB, 1094 COVID-19/HIV/TB, 5 SARS-CoV/TB, 2 MERS-CoV/TB and 1 SARS-CoV/HIV/TB. Four cohort studies [
 <xref ref-type="bibr" rid="CR41">41</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>, 
 <xref ref-type="bibr" rid="CR45">45</xref>, 
 <xref ref-type="bibr" rid="CR48">48</xref>], one case control study [
 <xref ref-type="bibr" rid="CR38">38</xref>] and four case series [
 <xref ref-type="bibr" rid="CR28">28</xref>, 
 <xref ref-type="bibr" rid="CR29">29</xref>, 
 <xref ref-type="bibr" rid="CR34">34</xref>, 
 <xref ref-type="bibr" rid="CR49">49</xref>] were conducted in China, two case series [
 <xref ref-type="bibr" rid="CR30">30</xref>, 
 <xref ref-type="bibr" rid="CR39">39</xref>] were done in Singapore, one case series [
 <xref ref-type="bibr" rid="CR32">32</xref>] and one case control study [
 <xref ref-type="bibr" rid="CR37">37</xref>] were undertaken in Saudi Arabia, a case series [
 <xref ref-type="bibr" rid="CR40">40</xref>] was conducted in Italy, one cohort study was done in South Africa [
 <xref ref-type="bibr" rid="CR42">42</xref>] and another in the Philippines [
 <xref ref-type="bibr" rid="CR43">43</xref>], one case study was conducted in the United State of America [
 <xref ref-type="bibr" rid="CR35">35</xref>], other three case studies were found in Turkey [
 <xref ref-type="bibr" rid="CR36">36</xref>], Hong Kong [
 <xref ref-type="bibr" rid="CR31">31</xref>] and India [
 <xref ref-type="bibr" rid="CR33">33</xref>] respectively. Lastly, a retrospective cohort was undertaken in eight countries (Italy, Belgium, Brazil, France, Russia, Singapore, Spain, and Switzerland) [
 <xref ref-type="bibr" rid="CR47">47</xref>].
</p>
